🔴 CalciMedica is trading 5% down today as it pulls back from a multi-day rally following FDA trial alignment

CalciMedica is trading at $0.95 (5% down) in after-hours trading, pulling back slightly after a sharp multi-day rebound.

• The recent upside was driven by FDA alignment on the design and endpoints for its planned Phase 2b acute pancreatitis trial, which boosted investor sentiment earlier this week.
• Shares appear to be consolidating recent gains as after-hours liquidity remains thin and volatility remains elevated.